ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,717Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 16

$367K Total Retail Price of All Prescriptions

Rank: 6 out of 16

326 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

29% of this provider’s 326 patients filled at least one prescription for a schedule two drug, compared to an average of 17%.

Schedule Three
Controlled Substances

16% of this provider’s 326 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 8,964 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $44 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
CITALOPRAM HBR 417 401 1 3
HYDROCODONE-ACETAMINOPHEN 379 338 S3 2 25
WARFARIN SODIUM 364 354 3 5
FUROSEMIDE 355 330 4 2
LEVOTHYROXINE SODIUM 319 291 5 1
POLYETHYLENE GLYCOL 3350 310 263 6 11
RANITIDINE HCL 293 267 7 22
OMEPRAZOLE 279 256 8 6
METOPROLOL TARTRATE 277 265 9 7
MIRTAZAPINE 241 214 10 17
LISINOPRIL 236 230 11 4
GABAPENTIN 211 207 12 10
NAMENDA 198 188 13 20
POTASSIUM CHLORIDE 195 188 14 13
PREDNISONE 184 184 15 23
AMLODIPINE BESYLATE 135 135 16 9
OXYCODONE HCL 134 130 S2 17 15
QUETIAPINE FUMARATE 127 127 18 27
OXYCONTIN 114 111 S2 19 54
DIVALPROEX SODIUM 112 82 20 24
TRAMADOL HCL 109 109 21 29
CARVEDILOL 106 103 22 38
ISOSORBIDE MONONITRATE ER 106 106 22 46
SERTRALINE HCL 101 89 24 19
SIMVASTATIN 101 94 24 8
CYMBALTA 100 100 26 43
TAMSULOSIN HCL 97 79 27 32
TAMIFLU 89 82 28 72
FLUOXETINE HCL 87 55 29 55
LANTUS 85 68 30 30
CARBIDOPA-LEVODOPA 81 81 31 35
MORPHINE SULFATE ER 78 78 S2 32 64
HALOPERIDOL 77 74 33 41
FENTANYL 72 71 S2 34 91
OLANZAPINE 72 55 34 50
RISPERIDONE 71 69 36 31
METOPROLOL SUCCINATE 71 60 36 16
NOVOLOG 71 62 36 37
DIGOXIN 69 69 39 48
MORPHINE SULFATE 65 61 S2 40 78
SEROQUEL 63 59 41 60
ALBUTEROL SULFATE 61 60 42 34
MAPAP 59 59 43 28
VENLAFAXINE HCL ER 57 53 44 66
GLIMEPIRIDE 56 56 45 81
CLOPIDOGREL 52 52 46 68
LOSARTAN POTASSIUM 52 52 46 39
METFORMIN HCL 52 41 46 33
PRAMIPEXOLE DIHYDROCHLORIDE 51 51 49 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 26, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.